Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)
Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
Investigator-initiated, multi-centre, randomised, open-label trial of nebulised heparin
sodium in addition to standard care compared to standard care alone in hospitalised patients
with COVID-19 infection.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Australian National University
Collaborators:
John Hunter Hospital Royal North Shore Hospital St George Hospital, Australia St Vincent's Hospital Melbourne The George Institute